2. Academic Validation
  3. Novel Azaquinolones as PARP1 Inhibitors for Treating Cancer

Novel Azaquinolones as PARP1 Inhibitors for Treating Cancer

  • ACS Med Chem Lett. 2021 Mar 16;12(4):524-525. doi: 10.1021/acsmedchemlett.1c00122.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States.
PMID: 33859786 DOI: 10.1021/acsmedchemlett.1c00122
Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-162114
    PARP1 Inhibitor